Collectively, these data indicate that CD8+ T cell-restricted peptides originating from self-tumor antigens like hTERT and WT-1 activate not only self-reactive CD8+ T cells but also are likely to cross-activate CD4+ T cells, including Foxp3+ Treg cells with self-reactive TCRs. The gene discussed is CD4; the disease is neoplasm.